Literature DB >> 21917439

CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

Kathryn Haskins1, Anne Cooke.   

Abstract

Pathogenesis of type 1 diabetes (T1D) is mediated by effector T cells and CD4 Th1 and Th17T cells have important roles in this process. While effector function of Th1 cells is well established, because of their inherent plasticity Th17 cells have been more controversial. Th17 cells contribute to pathogenicity, but several studies indicate that Th17 cells transfer disease through conversion to Th1 cells in vivo. CD4T cells are attracted to islets by β-cell antigens which include insulin and the two new autoantigens, chromogranin A and islet amyloid polypeptide, all proteins of the secretory granule. Peptides of insulin and ChgA bind to the NOD class II molecule in an unconventional manner and since autoantigenic peptides may typically bind to MHC with low affinity, it is postulated that post-translational modifications of β-cell peptides could contribute to the interaction between peptides, MHC, and the autoreactive TCR.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917439      PMCID: PMC3940273          DOI: 10.1016/j.coi.2011.08.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  55 in total

Review 1.  What makes an autoantigen an autoantigen?

Authors:  Chih-Te Wu; M Eric Gershwin; Paul A Davis
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

2.  CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

Authors:  Rocky L Baker; David H Wagner; Kathryn Haskins
Journal:  J Autoimmun       Date:  2008-10-31       Impact factor: 7.094

Review 3.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Authors:  Sally C Kent; Yahua Chen; Lisa Bregoli; Sue M Clemmings; Norma Sue Kenyon; Camillo Ricordi; Bernhard J Hering; David A Hafler
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.

Authors:  Boris Calderon; Javier A Carrero; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

6.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

7.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

Authors:  Greig P Lennon; Maria Bettini; Amanda R Burton; Erica Vincent; Paula Y Arnold; Pere Santamaria; Dario A A Vignali
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

8.  Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.

Authors:  Feng-Cheng Chou; Shing-Jia Shieh; Huey-Kang Sytwu
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

9.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Authors:  Juliet A Emamaullee; Joy Davis; Shaheed Merani; Christian Toso; John F Elliott; Aducio Thiesen; A M James Shapiro
Journal:  Diabetes       Date:  2009-03-16       Impact factor: 9.461

View more
  38 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.

Authors:  T Saksida; M Vujicic; I Nikolic; I Stojanovic; G Haegeman; S Stosic-Grujicic
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

3.  Novel autoantigens in type 1 diabetes.

Authors:  Shuhong Han; William Donelan; Hai Wang; Westley Reeves; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

4.  ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.

Authors:  Laura A Solt; Subhashis Banerjee; Sean Campbell; Theodore M Kamenecka; Thomas P Burris
Journal:  Endocrinology       Date:  2015-01-05       Impact factor: 4.736

5.  Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.

Authors:  Ma José Jerez; Miguel Jerez; Coral González-García; Sara Ballester; Ana Castro
Journal:  J Comput Aided Mol Des       Date:  2013-01-08       Impact factor: 3.686

Review 6.  Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells.

Authors:  Jan Novak; Lucie Novakova
Journal:  Clin Exp Med       Date:  2012-07-24       Impact factor: 3.984

7.  Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation.

Authors:  Sera Oh; Ji Hyun Shin; Eun Jung Jang; Hee Yeon Won; Hyo Kyeong Kim; Mi-Gyeong Jeong; Kwang Soo Kim; Eun Sook Hwang
Journal:  Biochem Biophys Res Commun       Date:  2016-04-22       Impact factor: 3.575

8.  Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.

Authors:  Fang Zou; Xiaoyang Lai; Jing Li; Shuihong Lei; Lei Hu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.

Authors:  Xin Huang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 10.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.